Prosthesis for inguinal hernia

Information

  • Patent Grant
  • 11471256
  • Patent Number
    11,471,256
  • Date Filed
    Wednesday, September 12, 2018
    5 years ago
  • Date Issued
    Tuesday, October 18, 2022
    a year ago
Abstract
The present invention relates to a prosthesis (1) for the repair of an inguinal hernia, which prosthesis (1) is intended to be implanted by a posterior or open laparoscopic route and comprises: an openworked textile (2) made of biocompatible material, comprising a first face (2a) intended to be placed facing the biological tissues of the inguinal region, and a second face (2b) arranged opposite said first face and intended to be placed facing the peritoneum, said first face being provided with fastening means that are able to fix said textile in said biological tissues of the inguinal region, characterized in that at least a part of said second face (2b) is covered with a non-porous coating (7) composed of a material that is hydrosoluble at 37° C. and non-hydrosoluble at 25° C. The invention also relates to a method for producing such a prosthesis.
Description
BACKGROUND

The present invention relates to a prosthesis for the repair of hernias, and in particular a prosthesis adapted for the repair of inguinal hernias by laparoscopy.


In a general manner, prostheses for the repair of the inguinal region and for the treatment of hernias comprise an openworked prosthetic textile which is made of biocompatible synthetic material and may or may not be absorbable, depending on whether the prosthesis is intended to remain permanently in the body of the patient or, by contrast, is intended to disappear once cell recolonization has taken place.


When repair of a hernia in the inguinal region is performed by a posterior and extraperitoneal laparoscopic route, it is important to be able to locate, and to cover with the prosthesis, certain anatomical elements of the anterior wall of the abdomen, which elements may be described as follows, from the inside outwards, and for the right-hand side of the body with reference to FIG. 1:

    • to the inside, the anterior retro-parietal space is limited towards the front by the rectus abdominis muscles 16, towards the rear by the peritoneum (not shown), and underneath by the upper margin of the os pubis 17;
    • the middle part is limited towards the front by the fascia transversalis (not shown), and the conjoint tendon, with the iliac vessels 11 below, and with the transverse muscle 18 above;
    • in the outer part, towards the front there is the internal orifice 19 of the inguinal canal with the elements of the spermatic cord (spermatic vessels and ductus deferens), with the psoas muscle 12 below, and with the transverse muscle 18 above.


The peritoneum is not shown in FIG. 1: it is situated between FIG. 1 and the person looking at FIG. 1. An inguinal hernia is a swelling of the groin caused when a portion of the peritoneum, possibly containing abdominal viscera, passes through the orifice 19 of the inguinal canal. It is necessary to protect this orifice 19 and to push the peritoneum, and possibly the abdominal viscera, back in the direction of the abdominal cavity, and place a barrier, namely a prosthesis, between the peritoneum and the orifice 19 of the inguinal canal.


It will be noted in FIG. 1 that the elements described above are not all in the same spatial plane, but instead are arranged in an oblique arrangement from the top downwards and from the outside inwards. In the case of an inguinal hernia, the prosthesis implanted after reduction of the hernia must ensure satisfactory covering by adapting to the contours of the region and by respecting the obliqueness of the inguinal space, if possible without leaving any empty spaces.


When operating using a posterior and extra-peritoneal route, whether by open surgery or by laparoscopy, the surgeon has to bring the prosthesis into this inguinal region and then place it correctly with respect to all the elements described above.


Furthermore, in order to shorten the duration of an intervention and thereby minimize the number of steps to be performed during an operation, it is possible to use prostheses made from an arrangement of yarns, a knit, a woven or non-woven fabric, comprising barbs protruding outwards from one face of the prosthesis: these barbs constitute structures such as hooks that are able to fix themselves directly in the biological tissues, for example the elements of the inguinal region that have been described above. With such prostheses, it is possible to dispense with steps involving fixing by sutures or staples.


The laparoscopic route requires only very small incisions for the passage of a trocar, through which the prosthesis is delivered to the implantation site. Open surgery is thus avoided, and the patient is soon able to leave hospital. The laparoscopic route is particularly prized in surgical interventions performed in the region of the abdomen, for example in the treatment of hernias.


However, the trocars used in the laparoscopic approach generally have a relatively small calibrated diameter, which can vary from 5 to 15 mm for example, in order to reduce as much as possible the size of the incision that is made. The prosthesis therefore has to be delivered through a conduit of small diameter, and it then has to be deployed at the implantation site.


To perform this step, the prosthesis is generally rolled up on itself, so as to slide it into the conduit of the trocar, or introduced directly with force. However, when the prosthetic textile forming the prosthesis comprises barbs on one face, it can happen that these barbs catch in the body of the textile, thus making subsequent deployment of the prosthesis at the implantation site more difficult. Moreover, because of the obliqueness of the inguinal region and the restricted deployment space, it can prove complicated to deploy the prosthesis and then orient it suitably with respect to the orifice of the inguinal canal.


Therefore, there is still a need for a prosthesis for repair of inguinal hernias that is capable of being delivered through a conduit, such as that of a trocar, to the inguinal region and that is then capable of deploying completely, and preferably easily, and of being oriented and positioned easily once the implantation site in the patient's body has been reached.


The present invention aims to meet such a need.


SUMMARY

A first aspect of the invention is a prosthesis for repair of an inguinal hernia, which prosthesis is intended to be implanted by a posterior or open laparoscopic route and comprises:


an openworked textile made of biocompatible material, comprising a first face intended to be placed facing the biological tissues of the inguinal region, and a second face arranged opposite said first face and intended to be placed facing the peritoneum,


said first face being provided with fastening means that are able to fix said textile in said biological tissues of the inguinal region,


characterized in that at least a part of said second face is covered with a non-porous coating consisting in a material that is hydrosoluble at 37° C. and non-hydrosoluble at a temperature of less than or equal to 25° C.


The present application also relates to a method for producing a prosthesis of the above type, characterized in that it comprises the following steps:


an openworked textile of biocompatible material is made available comprising a first face, provided with fastening means that are able to fix said textile in biological tissues of the inguinal region, and a second face,


at least a part of said second face is covered with a non-porous coating consisting in a material that is hydrosoluble at 37° C. and non-hydrosoluble at 25° C.


In the present application, “biological tissues of the inguinal region” are understood as the biological tissues of the organs or elements of the inguinal region that are shown in FIG. 1 and that are intended to be protected from the peritoneum with a view to repairing the hernia, and in particular the anterior muscle wall, the upper part of the os pubis and of Cooper's ligament, the iliac and spermatic vessels, and part of the psoas muscle.


According to the present application, “textile” is understood as any arrangement or assembly of biocompatible yarns, fibres, filaments and/or multifilaments, for example obtained by knitting, weaving, braiding, or non-woven. The arrangement of yarns of the textile according to the invention defines at least two opposite faces, namely a first face and a second face.


In the present application, “openworked textile” is understood as any textile in which the arrangement of yarns from which it is made defines openings, cells or holes within the thickness of the textile and on the faces of the textile, these openings, cells or holes being able to form channels opening out on each side of the textile. Such an openworked textile permits better tissue integration.


The textile according to the invention additionally comprises fastening means that are able to fix said textile in said biological tissues of the inguinal region. For example, these fastening means are barbs protruding from said first face. These fastening means or barbs can protrude from said first face in a manner substantially perpendicular to the plane of said face or, alternatively, in one or more planes inclined with respect to the plane of said face. These barbs are intended to function as fixing means by anchoring themselves in the biological tissues of the inguinal region.


The textile of the prosthesis according to the invention is covered at least partially on its second face, that is to say on its face opposite the face comprising the barbs, with a non-porous coating composed of a material that is hydrosoluble at 37° C. and non-hydrosoluble at 25° C.


In the present application, “hydrosoluble” is understood as the ability of a material to dissolve in an aqueous composition such as water or in the biological fluids at a given temperature. The hydrosoluble material of the coating of the prosthesis according to the invention has the ability to be hydrosoluble at 37° C. and thus able to dissolve in the biological fluids of a human body, but to be non-hydrosoluble at a temperature of less than or equal to 25° C. and therefore unable to dissolve in an aqueous composition between 20° C. and 25° C.


The time it takes to dissolve at 37° C., for example in the human body, is short, for example varying from 15 minutes to about 4 weeks.


The prosthesis according to the invention can be delivered easily to the implantation site, namely the inguinal region, by means of a trocar and can then be easily deployed at the implantation site. Indeed, the particular nature of the non-porous coating of the second face of the textile of the prosthesis according to the invention makes it possible both to hydrate the prosthesis before its introduction into the trocar and also to fold it optimally in order to facilitate its passage through the trocar and also its subsequent deployment. Indeed, the non-hydrosoluble nature of the non-porous coating at 25° C. makes it possible to hydrate the prosthesis at ambient temperature, that is to say at a temperature ranging from 20 to 25° C., without compromising the integrity of said coating. It has been found that, with prior hydration of this kind, the textile, and therefore the prosthesis, could be made more pliable and therefore easier to manipulate so as to fold it optimally for easy passage through the trocar and for optimized deployment on leaving the trocar. Thus, once it has been hydrated, it is possible for the prosthesis according to the invention to be folded such that most of the fastening means find themselves in contact with said non-porous coating, which has not yet dissolved. Thus, the fastening means of the first face of the textile do not in practice catch in the openings of the second face of the same textile, even when the prosthesis is pushed through the trocar, in which it is subject to the stress exerted by the inner walls of the trocar.


Thus, when the prosthesis leaves the trocar and arrives in the inguinal region, the fastening means are not entangled in the textile, and the prosthesis according to the invention can be easily deployed. At the implantation site in the human body, where the temperature is about 37.5° C., the non-porous coating dissolves upon contact with the aqueous biological fluids. Therefore, this avoids an excessive amount of foreign material being introduced long-term into the patient.


In one embodiment of the invention, said non-porous coating is present over the whole of the second face of said textile. It thus suffices to roll up the textile of the prosthesis according to the invention on itself, for example with the fastening means to the outside, in order to form a roll of the prosthesis that can be introduced into and then pushed through a trocar. Since the fastening means are thus in contact with the non-porous coating, they do not become entangled in the openings of the textile, and the deployment of the prosthesis when it leaves the trocar is easy.


In one embodiment of the prosthesis according to the invention, with said textile having the overall shape of a rectangle with length L and width l, said textile determines in the direction of its width l a first part called the upper part, intended to be placed facing the anterior muscle wall, the upper part of the os pubis and Cooper's ligament, and a second part called the lower part, intended to be placed facing the iliac and spermatic vessels and part of the psoas muscle, said non-porous coating being present on the second face of the textile over at least an upper region of said upper part.


Thus, as will be explained later in the detailed description, it is possible to fold the textile of the prosthesis of the invention in such a way that the fastening means do not become entangled in the textile during the passage of the prosthesis through the trocar, and in such a way that the deployment of the prosthesis is easy when it leaves the trocar. In one embodiment of the invention, said porous coating is present only on said upper region of said upper part. By virtue of the specific folding of the prosthesis as explained below, such an embodiment not only allows the prosthesis to be delivered to the implantation site by trocar without the fastening means inconveniently catching and with easy deployment of said prosthesis, but also limits the amount of foreign material, such as the material of the non-porous coating, that is introduced into the patient's body and that has to be eliminated by the patient's metabolism. Therefore, said upper region, that is to say the surface of the second face of the textile covered by the non-porous coating, preferably represents approximately two thirds of the surface of said upper part. Such embodiments make it possible to fold the prosthesis to permit passage of the prosthesis through the trocar without the fastening means catching in the textile, while at the same time minimizing the amount of foreign material, such as the non-porous coating, introduced into the human body during implantation of the prosthesis.


In one embodiment of the prosthesis according to the invention, said non-porous coating consists in a mixture of pepsin-treated collagen and glycerol. An aspect of the invention is therefore a prosthesis for repair of an inguinal hernia, which prosthesis is intended to be implanted by a posterior or open laparoscopic route and comprises:


an openworked textile made of biocompatible material, comprising a first face intended to be placed facing the biological tissues of the inguinal region, and a second face arranged opposite said first face and intended to be placed facing the peritoneum,


said first face being provided with fastening means that are able to fix said textile in said biological tissues of the inguinal region,


characterized in that at least a part of said second face is covered with a non-porous coating consisting in a mixture of pepsin-treated collagen and glycerol. The collagen can be oxidized or non-oxidized. Such a mixture makes it possible to obtain a non-porous coating that does not dissolve upon contact with an aqueous composition at a temperature of 20-25° C. but that does dissolve in the human body at 37° C., within a period of between 15 minutes and 4 weeks, and that is then eliminated naturally by the human metabolism.


The non-oxidized pepsin-treated collagen suitable for preparing the non-porous coating according to the invention can be prepared, for example, as follows: pigskins are ground in acid medium in order to obtain a paste, after which the dermis is precipitated in the presence of NaCl solution. The dermis is then degreased in the presence of solvents, then digested in the presence of hydrochloric acid and pepsin. After extraction of the pepsin, the product obtained is treated with sodium hydroxide (precipitation and viral deactivation) and then treated using hydrochloric acid, followed by drying in the presence of solvents.


In order to obtain a non-porous coating that takes longer to dissolve, it is possible to use oxidized pepsin-treated collagen. For example, the non-oxidized pepsin-treated collagen obtained above can be oxidized by treatment with periodic acid in the presence of hydrochloric acid. These chemical agents permit oxidation of hydroxylysine and therefore chemical cross-linking of the collagen on itself by subsequent increase in the pH of the solution of oxidized collagen.


The non-porous coating can, for example, be in the form of a film obtained by jellification of a solution containing a mixture of oxidized or non-oxidized pepsin-treated collagen and glycerol.


In one embodiment, said non-porous coating consists in a mixture of pepsin-treated collagen and glycerol and is in the form of a film, the surface density of pepsin-treated collagen ranging from 2 to 8 mg/cm2, and the surface density of glycerol ranging from 0.1 to 10 mg/cm2. The respective surface densities of the pepsin-treated collagen and of the glycerol in the film are calculated from the initial concentrations of these components in the solution prior to jellification.


In one embodiment, said non-porous coating consists in a mixture of non-oxidized pepsin-treated collagen and glycerol and is in the form of a film, the surface density of non-oxidized pepsin-treated collagen ranging from 2.6 to 8 mg/cm2, and preferably being approximately 5 mg/cm2, for example approximately 5.29 mg/cm2, and the surface density of glycerol ranging from 0.1 to 10 mg/cm2, and preferably being approximately 3 mg/cm2, for example approximately 2.35 mg/cm2. Such embodiments allow the non-porous coating to rapidly dissolve upon contact with the biological fluids at 37° C., for example within a period of between 15 minutes and 48 hours. Moreover, it has been found that a textile in which at least a part of said second face is covered with a non-porous coating of this kind provides a reduction in the catching points, during passage through a trocar, of at least 50% compared to the same textile without any coating.


In another embodiment of the prosthesis according to the invention, said non-porous coating comprises oxidized pepsin-treated collagen, optionally glycerol and optionally polyethylene glycol. Thus, in one embodiment, said non-porous coating comprises oxidized pepsin-treated collagen, optionally glycerol and optionally polyethylene glycol and is in the form of a film, the surface density of oxidized pepsin-treated collagen ranging from 2 to 7 mg/cm2, and preferably being approximately 3.6 mg/cm2, the surface density of glycerol ranging from 0 to 3 mg/cm2, and preferably being approximately 0.72 mg/cm2, the surface density of polyethylene glycol ranging from 0 to 2.5 mg/cm2, and preferably being approximately 1.21 mg/cm2. Like above, the respective surface densities of the oxidized pepsin-treated collagen and of the optional other components in the film are calculated from the initial concentrations of these components in the solution prior to jellification. Such an embodiment allows less rapid dissolution of the non-porous coating upon contact with the biological fluids at 37° C., for example within a period of 1 to 4 weeks. Moreover, it has been found that a textile in which at least a part of said second face is covered with a non-porous coating of this kind provides a reduction in the catching points, during passage through a trocar, of at least 50% compared to the same textile without any coating. A non-porous coating of this kind also allows adherences to be minimized.


In other embodiments of the prosthesis according to the invention, the non-porous coating comprises polyvinyl alcohol, optionally glycerol and optionally polyethylene glycol. Thus, in one embodiment, said non-porous coating comprises polyvinyl alcohol, optionally glycerol and optionally polyethylene glycol and is in the form of a film, the surface density of polyvinyl alcohol ranging from 2 to 7 mg/cm2, and preferably being approximately 3.6 mg/cm2, the surface density of glycerol ranging from 0 to 3 mg/cm2, and preferably being approximately 0.72 mg/cm2, and the surface density of polyethylene glycol ranging from 0 to 2.5 mg/cm2, and preferably being approximately 1.21 mg/cm2.


In one embodiment of the prosthesis according to the invention, the prosthesis is provided with a means for indicating the orientation of the prosthesis.


As has been seen above, the specific nature of the inguinal region, which is not symmetrical, means that the orientation of the prosthesis is imperative during implantation. This is because the upper part of the prosthesis often has a larger surface than the lower part. It is therefore imperative that the upper part of the prosthesis is correctly positioned facing the anterior muscle wall, the upper part of the os pubis and Cooper's ligament, and that the lower part of the prosthesis is correctly positioned facing the iliac and spermatic vessels and part of the psoas muscle. For example, said means for indicating the orientation of the prosthesis is in the form of a zone having a different colour than the rest of the prosthesis. In one embodiment of the invention, with said textile being in the form of a knit, the zone of different colour is obtained by knitting with a yarn of a different colour than the yarn or yarns used for knitting the rest of said textile. Such an embodiment therefore requires only a single knitting step in order to produce both the textile forming the prosthesis and also the means for indicating the orientation of this prosthesis. The method of production of the prosthesis is thus optimized. Moreover, since said means for indicating the orientation of the prosthesis is therefore integral with said textile, there is no risk of its detaching from the prosthesis. In particular, there is no risk of its being damaged during passage of the prosthesis through the trocar for delivering the prosthesis to the implantation site.


In one embodiment of the invention, said means for indicating the orientation of the prosthesis is situated in a medial part of the prosthesis. Within the context of the present application, “medial part” is understood as the part situated in the direction of the median plane of the human body. Thus, in the case where the means for indicating the orientation of the prosthesis according to the invention is, for example, a band with a colour different than the rest of the prosthesis, and this band is situated in the medial part of the prosthesis, the surgeon immediately knows that he has to direct this band of colour towards the os pubis when positioning the prosthesis. The surgical manoeuvre is thus made easier for him.


In one embodiment of the invention, said textile comprises a seam that at least partially delimits a border between said upper part and said lower part, said seam generally following an oblique line that starts from a starting point situated in the lower portion of a side of width l of said rectangle and terminates at an end point situated approximately at two thirds of the length L of the rectangle and half way along the width l of the rectangle. Thus, the seam can also serve as a positioning guide for the surgeon, this seam preferably having to be placed in the inguinal region at the intersection of the parietal and vascular planes to permit optimal positioning of the prosthesis. In one embodiment of the invention, said seam forms a fold of the textile, said fold causing said lower part of said textile to form naturally an angle to the plane of said upper part of said textile. Thus, the seam can give the textile a three-dimensional shape, similar to the anatomy of the inguinal region, by forming a fold in the textile, in such a way that the lower part of the textile tends naturally to form an angle with the upper part of said textile, this angle corresponding to the angle formed anatomically by the intersection of the parietal and vascular planes.


In one embodiment of the prosthesis according to the invention, said textile is a knit based on at least a first yarn of biocompatible polymer material defining said first and second faces, and at least a second yarn in the form of a biocompatible hot-melt monofilament forming said fastening means by melting of loops generated by said second yarn, the pattern chart followed for knitting said first and second yarns on a warp knitting machine with three guide bars B1, B2, B3 being the following, according to the standard ISO 11676:

    • Bar B1: 1.0/0.1//
    • Bar B2: 1.0/7.7/6.6/7.7//
    • Bar B3: 2.1/50.5/3.4/0.0//


said second yarn following the pattern chart of bar B3.


Such an embodiment makes it possible to optimize the formation of the openings of the textile in order to further limit the possibilities of entanglement of the fastening means in the textile.


In one embodiment of the invention, said first yarn is a monofilament yarn of polyethylene terephthalate (PET) and said second yarn is a monofilament yarn of polylactic acid (PLA). Such an embodiment makes it possible to obtain a textile that further limits the possibilities of entanglement of the fastening means in the textile, since the different monofilament yarns are less likely than multifilament yarns to catch the fastening means.


The present application also describes a method for treatment of an inguinal hernia, comprising the following steps:

    • a prosthesis as described above is made available,
    • said prosthesis is hydrated with an aqueous composition, for example a saline solution of 9% NaCl,
    • the prosthesis is folded by first of all folding the lower part of the prosthesis onto the lower region of the upper part, with the fastening means to the outside, after which the assembly is folded onto the upper region of the upper part of the textile, onto the second face covered with the non-porous coating,
    • the prosthesis, thus folded, is introduced into a trocar in order to deliver the prosthesis to the implantation site in the inguinal region,
    • the prosthesis is easily deployed, the fastening means not being entangled in the textile,
    • by virtue of the indicating means of the prosthesis, for example the band that has a colour different than the rest of the textile and that is situated in the medial part of the prosthesis, this medial part is oriented in the direction of the os pubis,
    • the prosthesis is fitted in place facing the surrounding biological tissues, by positioning the upper part of the textile facing the anterior muscle wall, the upper part of the os pubis and Cooper's ligament, and the lower part of the textile facing the iliac and spermatic vessels and part of the psoas muscle, if appropriate with the aid of the seam, by placing the latter at the intersection of the parietal and vascular planes, the first face provided with the barbs being placed against the biological tissues of the inguinal region, and the second face, of which the non-porous coating dissolves upon contact with the biological fluids at 37° C., being placed against the peritoneum.


During the hydration of the prosthesis, before its introduction into the trocar, the non-porous coating maintains its integrity: it does not dissolve in the saline composition since the temperature does not exceed 25° C. Thus, the prosthesis can be easily folded to permit optimal passage through the trocar. Once the prosthesis has been delivered to the implantation site, with the biological fluids of the patient's body being at a temperature of close to 37° C., the non-porous coating dissolves.


By virtue of the fastening means, such as barbs, the prosthesis of the invention fixes naturally to the biological tissues of the inguinal region.





BRIEF DESCRIPTION OF THE DRAWINGS

The advantages of the present invention will become clearer from the following detailed description and example and from the attached drawings, in which:



FIG. 1 is a perspective view of the inguinal region on the right-hand side of a human body,



FIG. 2 is a perspective view of a prosthesis according to the invention,



FIG. 3 is a top view of the textile used for producing the prosthesis of FIG. 2,



FIG. 4 is a bottom view of the textile used for producing the prosthesis of FIG. 2,



FIG. 5 is a top view of the textile used for producing a variant of the prosthesis according to the invention,



FIG. 6 is a cross-sectional view of the prosthesis of FIG. 2 in the plane I-I′,



FIG. 7 is a perspective view of the prosthesis of FIG. 2 once implanted and positioned with respect to the anatomical elements of the extraperitoneal inguinal region, on the right-hand side of a human body, seen from the inside outwards, that is to say towards the outside of the body,



FIGS. 8A to 8C show the pattern charts followed for knitting a textile suitable for a prosthesis according to the invention,



FIGS. 9A to 9C show side views of the prosthesis of FIG. 2 during three steps for specific folding of the prosthesis,



FIG. 10 is a partial top view of a knit suitable for the prosthesis according to the invention and comprising a means for indicating the orientation of the prosthesis.





DETAILED DESCRIPTION

Referring to FIGS. 2 to 4, these show a prosthesis 1 according to the invention for the repair of an inguinal hernia, comprising an openworked textile 2 with two opposite faces, namely a first face 2a and a second face 2b. In FIG. 2, the prosthesis 1 has a three-dimensional shape on account of the presence of a seam 4 forming a fold in the textile 2, such that a lower part 5 of the textile 2 tends naturally to form an angle with an upper part 6 of said textile 2, this angle corresponding to the angle formed anatomically by the intersection of the parietal and vascular planes, as will be seen hereinbelow in the description. FIGS. 3 and 4 show the textile 2 in the flat state before formation of the seam 4, with its second face 2b to the top and its first face 2a to the top, respectively.


The textile 2 can be any arrangement or assembly of biocompatible yarns, fibres, filaments and/or multifilaments, obtained by knitting, weaving, braiding, or non-woven, said arrangement defining openings, cells or holes within the thickness of the textile and on the faces of the textile, these openings, cells or holes being able to form channels opening out on each side of the textile 2. Such an openworked textile 2 permits better tissue integration.


The yarns or fibres or filaments and/or multifilaments forming the arrangement of yarns constituting the textile 2 of the prosthesis according to the invention can be made of any biodegradable or non-biodegradable biocompatible material. Thus, the biodegradable materials suitable for the yarns of the textile 2 of the prosthesis 1 according to the present invention can be chosen from polylactic acid (PLA), polyglycolic acid (PGA), oxidized cellulose, polycaprolactone (PCL), polydioxanone (PDO), trimethylene carbonate (TMC), polyvinyl alcohol (PVA), polyhydroxyalkanoates (PHAs), copolymers of these compounds and mixtures thereof. The non-biodegradable materials suitable for the yarns of the textile 2 of the prosthesis 1 according to the present invention can be chosen from polyethylene terephthalate (PET), polyamides, aramids, expanded polytetrafluoroethylene, polyurethane, polyvinylidene difluoride (PVDF), polybutyl esters, polyetheretherketone (PEEK), polyolefins (such as polyethylene or polypropylene), polyethers, copper alloys, silver alloys, platinum, medical grades of steel such as medical-grade stainless steel, and combinations thereof.


Referring to FIGS. 4 and 6, the first face 2a of the textile 2 is provided with fastening means, represented in these figures in the form of barbs 3 jutting out from said first face 2a. These fastening means are able to fix said textile in said biological tissues of the inguinal region. These fastening means or barbs 3 can protrude from said first face 2a in a manner substantially perpendicular to the plane of said face 2a or, alternatively in an embodiment not shown, in one or more planes inclined with respect to the plane of said face.


The fastening means, for example the barbs 3, of the textile 2 of the prosthesis according to the invention can be formed from yarns, for example hot-melt monofilament yarns issuing directly from the arrangement of yarns forming the textile. Textiles and barbs of this kind, and the method of producing them, are described, for example, in the applications WO01/81667 and DE 198 32 634 or in the U.S. Pat. Nos. 6,596,002 and 5,254,133.


For example, the barbs 3 are formed from monofilament yarns made of polylactic acid.


Alternatively, the fastening means, for example the barbs, of the textile of the prosthesis according to the invention can be any kind of hook made entirely from biocompatible material and integral with the arrangement of yarns forming said textile, irrespective of whether these hooks have been incorporated in said fabric during the manufacture (braiding, knitting, weaving, etc.) of said arrangement of yarns or have been attached later.


Preferably, as is shown in FIG. 6, the fastening means are barbs 3 in the shape of a stalk topped by a head; the average size of the heads of the barbs varies in general from 300 μm to 500 μm.


Textiles with barbs suitable for the present invention are described in WO01/81667, for example, or are also commercially available from the company Sofradim Production under the trade name Parietex® Progrip or Parietene® Progrip.


In one embodiment, the textile 2 is a knit based on at least a first yarn of biocompatible polymer material defining said first and second faces (2a, 2b) and at least a second biocompatible hot-melt monofilament yarn forming said fastening means by melting of loops generated by said second yarn, the pattern chart followed for knitting said first and second yarns on a warp knitting machine with three guide bars B1, B2, B3 being the following, according to the standard ISO 11676:

    • Bar B1: 1.0/0.1//
    • Bar B2: 1.0/7.7/6.6/7.7//
    • Bar B3: 2.1/50.5/3.4/0.0//


said second yarn following the pattern chart of bar B3.


The above pattern chart is illustrated in FIGS. 8A to 8C for bar B1, bar B2 and bar B3, respectively, in a representation well known to a persn skilled in the art. A pattern chart of this kind, followed for knitting the yarns of the knit, generates a particular structure of the textile 2, that is to say a specific arrangement between the different openings in the faces of the textile 2, the respective size of these different openings and the disposition and distribution of the barbs 3 being such that, even if some of the barbs 3 present on the first face 2a come to be trapped within some of the openings present on the second face 2b when the prosthesis is rolled up on itself under the effect of an external stress, for example the stresses exerted by the surgeon when folding the prosthesis in order to introduce it into a trocar, then the stress exerted by the inner walls of the trocar, a large number of the trapped barbs 3 will be freed automatically or under the effect of a very weak unrolling force when said stress is relaxed.


Moreover, and also preferably, said first yarn is a monofilament yarn of polyethylene terephthalate (PET) and said second yarn is a monofilament yarn of polylactic acid (PLA).


The first yarn(s) of the knit according to the invention are those that follow the pattern charts for bars B1 and B2. They constitute the foundation or base of the knit of the prosthesis 1 according to the invention, since the second yarn, namely a hot-melt monofilament yarn, which generates the barbs 3, is regularly cut in the area of the loops that it forms. The generation of barbs from loops of hot-melt yarn is known and is described, for example, in the document WO01/81667. When the first yarn(s) are monofilament yarns, the possible presence of asperities or of points of fastening of the barbs is limited, and the force needed to unroll the knit after the prosthesis has been rolled up as described above is very low.


The textile 2 of the prosthesis according to the invention can have a thickness, including the length of the barbs 3, of from 1 to 2 mm, for example approximately 1.4 mm.


Referring to FIG. 3, in which the textile 2 is shown when flat and before production of the seam 4 which gives the prosthesis 1 its three-dimensional character, the second face 2b of the textile 2 is partially covered with a non-porous coating 7 consisting in a material that is hydrosoluble at 37° C. and non-hydrosoluble at 25° C.


For example, said non-porous coating consists in a mixture of pepsin-treated collagen and glycerol.


In one embodiment, said non-porous coating consists in a mixture of pepsin-treated collagen and glycerol and is in the form of a film, the surface density of pepsin-treated collagen ranging from 2 to 8 mg/cm2, and the surface density of glycerol ranging from 0.1 to 10 mg/cm2.


For example, said non-porous coating consists in a mixture of non-oxidized pepsin-treated collagen and glycerol and is in the form of a film, the surface density of non-oxidized pepsin-treated collagen ranging from 2.6 to 8 mg/cm2, and preferably being about 5.29 mg/cm2, and the surface density of glycerol ranging from 0.1 to 10 mg/cm2, and preferably being approximately 2.35 mg/cm2. Such an embodiment allows the non-porous coating to rapidly dissolve on contact with the biological fluids at 37° C., for example between 15 minutes and 48 hours. Moreover, it has been found that a textile in which at least part of said second face is covered with a non-porous coating of this kind provides a reduction in the catching points, during passage through a trocar, of at least 50% compared to the same textile without any coating.


In another embodiment of the prosthesis according to the invention, said non-porous coating comprises oxidized pepsin-treated collagen, optionally glycerol, and optionally polyethylene glycol. Thus, in one embodiment, said non-porous coating comprises oxidized pepsin-treated collagen, optionally glycerol and optionally polyethylene glycol and is in the form of a film, the surface density of oxidized pepsin-treated collagen ranging from 2 to 7 mg/cm2, and preferably being approximately 3.6 mg/cm2, the surface density of glycerol ranging from 0 to 3 mg/cm2, and preferably being approximately 0.72 mg/cm2, the surface density of polyethylene glycol ranging from 0 to 2.5 mg/cm2, and preferably being approximately 1.21 mg/cm2. Such an embodiment allows less rapid dissolution of the non-porous coating on contact with the biological fluids at 37° C., for example from 1 to 4 weeks. Moreover, it has been found that a textile in which at least part of said second face is covered with a non-porous coating of this kind provides a reduction in the catching points, during passage through a trocar, of at least 50% compared to the same textile without any coating. A non-porous coating of this kind also allows adherences to be minimized.


In other embodiments of the prosthesis according to the invention, the non-porous coating comprises polyvinyl alcohol, optionally glycerol, and optionally polyethylene glycol. Thus, in one embodiment, said non-porous coating comprises polyvinyl alcohol, optionally glycerol and optionally polyethylene glycol and is in the form of a film, the surface density of polyvinyl alcohol ranging from 2 to 7 mg/cm2, and preferably being approximately 3.6 mg/cm2, the surface density of glycerol ranging from 0 to 3 mg/cm2, and preferably being approximately 0.72 mg/cm2, and the surface density of polyethylene glycol ranging from 0 to 2.5 mg/cm2, and preferably being approximately 1.21 mg/cm2.


Referring to FIGS. 2, 3 and 7, the textile 2 when flat has the overall shape of a rectangle with length L and width l (see FIG. 3), the textile 2 determining in the direction of its width l a first part called the upper part 6, intended to be placed facing the anterior muscle wall (16, 18), the upper part of the os pubis 17 and Cooper's ligament 21, and a second part called the lower part 5, intended to be placed facing the iliac vessels 11 and spermatic vessels 20 and part of the psoas muscle. By way of example, L can be of the order of 15 cm and l can be of the order of 13 cm. Referring to FIG. 3, the upper part 6 of the textile 2 is separated at least partially from the lower part 5 by a line 8 indicating the place where the seam 4 of the prosthesis 1 of FIG. 1 will be made.


As will be seen from these figures and from FIG. 3, the non-porous coating is in the form of a film 7 which is present on an upper region 6a of the upper part 6 of the textile 2. This upper region 6a represents approximately two thirds of the surface of the upper part 6 of the textile 2. In particular, the non-porous coating 7 is present only on this upper region 6a of the upper part 6 of the textile 2. The advantage of such an embodiment will become clear later in the description.


In another embodiment of the prosthesis according to the invention, shown in FIG. 5, the prosthesis 101, and therefore the textile 102, has the shape of a rectangle. In the example shown, the non-porous coating 7 is present on the whole of the second face of the textile 102.


Referring to FIGS. 2-4, the prosthesis 1 is also provided with a means for indicating the orientation of the prosthesis, said indicating means being in the form of a band 9 having a colour different than the colour of the rest of the prosthesis 1, this band of colour 9 being situated in the medial part of the prosthesis 1. The “medial part” of the prosthesis is understood as the part of the prosthesis that will be situated in the direction of the median plane of the human body once the prosthesis has been implanted. When the textile 2 is a knit, as has been described above, the band 9 of different colour is obtained by knitting with a yarn of a different colour than the yarn or yarns used for knitting the rest of the textile 2.


Referring to FIGS. 2 and 3, the textile 2 comprises a seam 4 that at least partially delimits a border between said upper part 6 and said lower part 5, said seam 4 generally following an oblique line 8 (see FIG. 3) that starts from a starting point 8a situated in the lower portion of a side of width l of said rectangle and terminates at an end point 8b situated at approximately two thirds of the length L of the rectangle and half way along the width l of the rectangle. Moreover, the seam 4 forms a fold of the textile 2, said fold causing said lower part 5 of the textile 2 to form naturally an angle to the plane of the upper part of said textile 2, as is shown in FIG. 2. As will become clear from the description below, this angle preferably corresponds to the angle formed anatomically by the intersection of the parietal and vascular planes in the inguinal region, as has been described for FIG. 1.


Thus, by virtue of the presence of the seam 4, as will be seen from FIGS. 3 and 7, the upper part 6 is substantially planar, whereas the lower part 5 of the textile 2 of the prosthesis 1 has an undulated and anatomical developed shape for matching the general shape of the lower inguinal structures, especially the spermatic and iliac vessels and the psoas muscle, as will be seen from FIG. 7. The oblique line 8 followed by the seam 4 gives the latter a curved shape, the lower part 5 thus forming with the upper part 6 an angle corresponding to the angle formed by the parietal and vascular planes at the intersection thereof in the inguinal region of a human body. Thus, the upper part 6 and the lower part 5 are asymmetrical, which means that a left-hand prosthesis or right-hand prosthesis will be used depending on which side the hernia to be treated is located. As is shown in FIG. 7, the prosthesis of FIG. 2 is a prosthesis for the repair of an inguinal hernia on the right-hand side of a patient. A prosthesis suitable for the repair of an inguinal hernia on the left-hand side of a patient would have a shape the mirror image of the prosthesis 1 of FIG. 2.


Preferably, the upper part 6 can have a height of up to approximately 15 cm, and the lower part 5 can have a depth of between approximately 2 cm and approximately 6 cm.


A prosthesis of this kind ensures that all of the anatomical elements described above are covered, without leaving empty spaces that could possibly cause a recurrence. In particular, the region around the iliac and spermatic vessels is particularly well protected. This therefore avoids one of the main causes of secondary hernias, which can be even more difficult to treat on account of the deterioration of the anatomical structures that has been caused by the earlier hernia.


The prosthesis according to the invention, in particular the prosthesis 1 of FIGS. 2-4, can be produced as follows:

    • an openworked textile of biocompatible material is made available, such as the textile 2 in the figures, comprising a first face 2a provided with fastening means, such as barbs 3, that are able to fix said textile in biological tissues of the inguinal region, for example as described above, and a second face: the textile 2 can be a knit obtained in the shape of a rectangle, with the band of different colour already present, obtained by knitting, as described in Example 1 below;
    • a rectangular shape as shown in FIG. 5 or an anatomical shape as shown in FIG. 3 is cut from this rectangle, delimiting an upper part 6 and a lower part 5 of the textile 2;
    • if appropriate, the seam 4 is made along the line 8 (FIG. 3) by forming a fold in order to give the prosthesis a three-dimensional shape. The seam 4 is terminated at an end point 8a, as is described below. This three-dimensional shape ensures that the inguinal space is well covered;
    • at least a part of said second face is covered with a non-porous coating composed of a material that is hydrosoluble at 37° C. and non-hydrosoluble at 25° C.; the preparations of the composition of the non-porous coating and its application to the second face of the textile 2 is described in more detail in Example 1 below.


The use and the implantation of the prosthesis according to the invention will now be described with reference to the treatment of an inguinal hernia on the right-hand side of a patient by a posterior laparoscopic approach using the prosthesis 1 from FIGS. 2-4.


The technique used in the laparoscopic intervention, for example, is well known to a person skilled in the art and, consequently, will not be described in detail. In this technique, one or more trocars are introduced into the extraperitoneal space, that is to say posterior to the rectus abdominis muscle and the fascia transversalis, the extraperitoneal working space being created by insufflation and separation of the peritoneum and the abdominal wall.


The perspective views in FIGS. 1 and 7 show, on the one hand, the anatomical elements of the extraperitoneal inguinal region on the right-hand side of a human body, seen from the inside outwards, that is to say towards the outside of the body as has been described above, and, on the other hand, a view of the positioning of the prosthesis according to the present invention in relation to these elements once it has been implanted.


It can be clearly seen in FIG. 1 that the inguinal region is particular in that the elements described above are not all in the same spatial plane, but instead are arranged in an oblique arrangement from the top downwards and from the outside inwards. In the case of an inguinal hernia, the prosthesis implanted after reduction of the hernia must ensure satisfactory covering by adapting to the contours of the region and by respecting the obliqueness of the inguinal space.


To proceed with the intervention, the surgeon takes hold of the prosthesis 1 from FIG. 2 and hydrates this prosthesis 1 with an aqueous composition, for example a 9% NaCl saline solution. During the hydration of the prosthesis 1, before its introduction into the trocar intended to deliver it to the inguinal space, the non-porous coating 7 maintains its integrity: it does not dissolve in the saline composition since the temperature does not exceed 25° C. Thus, the prosthesis 1 can be easily folded, in particular specifically folded to permit optimal passage through the trocar and easy deployment of the prosthesis 1, as is described hereinbelow.


The folding of the prosthesis 1 from FIG. 2 is described hereinbelow with reference to FIGS. 9A to 9C. FIG. 9A shows a side view of the prosthesis 1 from FIG. 2 in its deployed configuration. The surgeon begins folding the prosthesis 1 by first of all folding the lower part 5 of the prosthesis 1 onto the lower region of the upper part 6 free of non-porous coating, with the fastening means, in other words the barbs 3, to the outside, as is shown in FIG. 9B; this first folding is performed along the seam line 4: these two parts are folded one onto the other, second face 2b on second face 2b, such that the barbs 3 cannot become entangled in the openings of the textile 2.


Referring to FIG. 9C, the surgeon then folds the assembly made up of “lower part 5+lower region of the upper part 6” onto the upper region 6a of the upper part 6 of the textile 2, onto the second face 2b covered with the non-porous coating 7. Thus, the barbs 3 of the lower part 5 are brought into contact with the non-porous coating 7, and not with the openings of the textile 2. By virtue of the pliability of the prosthesis 1, in particular of the textile 2, reinforced by the prior hydration of the prosthesis 1 as has been described above, this folding is easy to do, as is also the subsequent step of introducing the roll thereby obtained into a trocar (not shown), for example with an internal diameter of 10 mm.


As will be clear from the description of this folding, the presence of the non-porous coating 7 on only approximately two thirds of the surface of the upper part 6 of the textile 2 corresponds to an advantageous embodiment of the prosthesis 1 according to the invention. This is because this embodiment not only makes it possible to deliver the prosthesis 1 to the implantation site by trocar, without entanglement of the barbs 3 and with easy deployment of said prosthesis 1 as will be described hereinbelow, but also makes it possible to limit the amount of material constituting a foreign body, such as the material of the non-porous coating 7, that is introduced into the patient's body and that has to be eliminated by the patient's metabolism.


The surgeon then introduces the folded prosthesis 1 into the trocar in order to deliver the prosthesis to the implantation site in the inguinal region. Despite the stress exerted by the walls of the trocar, the barbs 3 do not become entangled in the openings of the textile 2 by virtue of the presence of the non-porous coating 7 which forms a barrier and does not dissolve.


Once it is at the implantation site, namely in the inguinal region as described with reference to FIG. 1, the prosthesis 1 is easily deployed by the surgeon, and the barbs 3 do not become entangled in the textile 2. Since the biological fluids of the patient's body are at a temperature close to 37° C., the non-porous coating 7 dissolves and is eliminated naturally by the patient.


By virtue of the band 9 that has a colour different than the colour of the rest of the prosthesis 1, and that is situated in the medial part of the prosthesis 1, the surgeon easily orients this medial part in the direction of the os pubis 17 (FIG. 7).


The surgeon fits the prosthesis 1 in place facing the surrounding biological tissues, by positioning the upper part 6 of the textile 2 facing the anterior muscle wall, the upper part of the os pubis 17 and Cooper's ligament 21, and the lower part 5 of the textile facing the iliac and spermatic vessels 11 and part of the psoas muscle, if appropriate with the aid of the seam 4, for example by placing the latter at the intersection of the parietal and vascular planes, the first face 2a provided with the barbs 3 being placed against the biological tissues of the inguinal region, and the second face 2b, of which the non-porous coating 7 dissolves on contact with the biological fluids at 37° C., being placed against the peritoneum (not shown).


By virtue of the barbs 3, the prosthesis 1 fixes naturally to the biological tissues of the inguinal region, and an additional step of fixing with staples or sutures is not necessary.


When the prosthesis 1 is implanted (reference may usefully be made to FIG. 7), the upper part 6 rests on the anterior muscle wall (especially the rectus abdominis muscle 16 and transverse muscle 18), the upper end of the os pubis and part of Cooper's ligament 21. The lower part 5 conforms almost completely, without leaving any appreciable spaces, to the iliac and spermatic vessels 11 and the psoas muscle 12, and the seam 4 is placed at the intersection of the parietal and vascular planes. The ductus deferens 20 is also covered and therefore protected.


The prosthesis 1 according to the invention remains in place by itself, particularly on account of its three-dimensional shape, since the seam 4 takes up a position at the intersection of the parietal and vascular planes. This allows the prosthesis 1 to follow the changes in the relative position of the various anatomical elements of the inguinal region, which changes result from the normal movement of the abdominal muscles of the subject, but without its moving away from the implantation region.


EXAMPLE 1

A prosthesis according to the invention is produced as follows:


1) Preparation of a Textile in the Form of a Knit in which the Means for Indicating the Orientation of the Prosthesis is Incorporated During Knitting


On a warp knitting machine with three guide bars B1, B2, B3, a knit was produced having the following pattern chart according to the standard ISO 11676:

    • Bar B1: 1.0/0.1//
    • Bar B2: 1.0/7.7/6.6/7.7//
    • Bar B3: 2.1/5.5/3.4/0.0//


These pattern charts are illustrated in FIGS. 8A to 8C in a representation known to a person skilled in the art: the pattern chart for bar B1 is illustrated in FIG. 8A, the pattern chart for bar B2 is illustrated in FIG. 8B, and the pattern chart for bar B3 is illustrated in FIG. 8C.


Bar B1 and bar B2 are each threaded 1 full, 1 empty, with a monofilament yarn of polyethylene terephthalate (PET) of diameter 0.09 mm; bar B3 is threaded 1 full, 3 empty, with a thermoplastic monofilament yarn of polylactic acid of diameter 0.15 mm.


The pattern chart for bar B3 causes the thermoplastic monofilament yarn of polylactic acid to form loops. These loops are then melted, as is described in WO01/81667, in order to form barbs protruding from the first face of the textile, each loop giving rise to two barbs. The barbs that are obtained generally have the shape of a stalk topped by a head, as is shown in FIG. 6: the average size of the heads of the barbs generally varies from 300 μm to 500 μm.


The knit obtained has a thickness, including the length of the barbs, of approximately 1.4 mm.


The pattern chart followed for knitting the yarns of the knit of the present example generates a particular structure of the textile, that is to say a specific arrangement between the different openings in the faces of the textile, the respective size of these different openings and the disposition and distribution of the barbs being such that, even if some of the barbs present on the first face are trapped within some of the openings present on the second face when the prosthesis is rolled up on itself under the effect of an external stress, for example the stresses exerted by the surgeon when folding the prosthesis in order to introduce it into a trocar, then the stress exerted by the inner walls of the trocar, a large number of the trapped barbs will be freed automatically or under the effect of a very weak unrolling force when said stress is relaxed. This effect is reinforced by the fact that the yarns used are monofilament yarns.


In order that the means for indicating the orientation of the prosthesis is incorporated during the above knitting phase, bars B1 and B2 are threaded over a certain distance with PET monofilament yarns of a first colour, for example white, then over a defined second distance with PET monofilament yarns of another colour, for example green, and this is repeated over the entire width of the knitting machine.


This results, for example, in a succession of white bands and green bands. For example, the white bands 31 have a width Ib of 31 cm, and the green bands 32 have a width Iv of 9 cm, as is shown in FIG. 10. It then suffices to cut each white band 31 at its middle and each green band 32 at its middle, as is shown in FIG. 10, in order to obtain knits of rectangular shape with a total length of 20 cm and with a band of different colour in the region of one of the small sides of the rectangle.


Again with reference to FIG. 10, it is possible, in each rectangular knit thus obtained, to cut out either a rectangular textile 102 comprising a colour band 9 with a view to producing a prosthesis 101 according to the invention as shown in FIG. 5, or a textile 2 comprising a colour band 9, an upper part 6 and a lower part 5 and also an oblique line 8, with a view to producing a prosthesis according to FIG. 2. In the latter case, a seam is formed along the line 8 by forming a fold in order to obtain a three-dimensional textile, as has been explained in the present application with reference to FIG. 2.


2) Preparation of the Composition Intended to Form the Coating of Non-Porous Material


Particles of non-oxidized pepsin-treated collagen are prepared by grinding pigskins in acid medium in order to obtain a paste, after which the dermis is precipitated in the presence of NaCl solution. The dermis is then degreased in the presence of solvents, then digested in the presence of hydrochloric acid and pepsin. After extraction of the pepsin, the product obtained is treated with sodium hydroxide (precipitation and viral deactivation) and then treated using hydrochloric acid, followed by drying in the presence of solvents.


The particles of pepsin-treated collagen are then mixed with stirring at 40° C. in a solution of glycerol in water: the pH of the composition obtained is adjusted to 7.0 using a solution of sodium hydroxide (NaOH).


The composition is then heated at 60° C. with stirring, then filtered. The temperature is then brought back to 40° C., and the pH is adjusted between 4.5 and 7.0 with either a base (NaOH) or an acid (HCl), if necessary.


The concentration of the composition is adjusted to 5.4% (w/w) for the collagen and to 2.4% (w/w) for the glycerol.


The composition is maintained at 40° C.


3) Application of the Composition Obtained Under 2) to a Textile Obtained Under 1), in the Form of a Film


The composition obtained under 2) is deposited on the second face 2b of the textile (2; 102):

    • either over the whole surface of the second face 2b in the case of the textile 102 of the prosthesis 101 of FIG. 5,
    • or only in the upper region 6a of the upper part 6 of the textile 2 in the case of the prosthesis 1 of FIGS. 2 and 3.


The composition is applied with a density of 0.092 ml/cm2. It forms a gel in approximately 45 minutes.


The assembly “textile+gelled composition” is then dried in air for 12 hours until a film is obtained.


In the film, the surface density of pepsin-treated collagen is approximately 5 mg/cm2, and the surface density of glycerol is approximately 3 mg/cm2.


This film is non-hydrosoluble at a temperature of 20 to 25° C. and is hydrosoluble at a temperature of approximately 37° C. It dissolves in the biological fluids in approximately 15 minutes.


Prostheses according to the invention are thus obtained, for example a prosthesis 101 according to FIG. 5, or a prosthesis 1 according to FIG. 2, and these prostheses, after hydration at 20-25° C., can be folded, introduced into a trocar and then easily deployed, as described in the present application.

Claims
  • 1. A method for producing a prosthesis, comprising: providing an openworked textile of biocompatible material comprising a first face, provided with fastening means that are able to fix said textile in biological tissues of an inguinal region, and a second face,heating a composition including particles of pepsin-treated non-oxidized collagen and glycerol to 60° C.,maintaining the composition at 40° C. following heating,covering at least a part of said second face with the composition to form a non-porous coating that is hydrosoluble at 37° C. and non-hydrosoluble at 25° C.
  • 2. The method according to claim 1, wherein covering at least a part of said second face comprises covering a whole of said second face of said openworked textile with the non-porous coating.
  • 3. The method according to claim 1, wherein said openworked textile further comprises an overall shape of a rectangle with a length and a width, and said openworked textile determines in the width direction a first upper part, intended to be placed facing an anterior muscle wall, an upper part of an os pubis and Cooper's ligament, and a second lower part, intended to be placed facing an iliac and spermatic vessels and part of a psoas muscle, and wherein covering at least a part of said second face comprises covering at least an upper region of said first upper part of said second face of said openworked textile with the non-porous coating.
  • 4. The method according to claim 3, wherein covering at least a part of said second face comprises covering only said upper region of said upper part with the non-porous coating.
  • 5. The method according to claim 4, wherein said upper region represents approximately two thirds of a surface of said upper part.
  • 6. The method according to claim 3, further comprising forming a seam on said textile, said seam at least partially delimiting a border between said upper part and said lower part, said seam generally following an oblique line that starts from a starting point situated in a lower portion of a side of the width of said rectangle and terminates at an end point situated approximately at two thirds of the length of the rectangle and half way along the width of the rectangle.
  • 7. The method according to claim 6, further comprising folding said textile along said seam to form a fold, said fold causing said lower part of said textile to form naturally an angle to a plane of said upper part of said textile.
  • 8. The method according to claim 1, wherein said non-porous coating comprises a film comprising a surface density of pepsin-treated collagen ranging from 2 to 8 mg/cm2 and a surface density of glycerol ranging from 0.1 to 10 mg/cm2.
  • 9. The method according to claim 1, wherein said non-porous coating comprises a film comprising a surface density of non-oxidized pepsin-treated collagen ranging from 2.6 to 8 mg/cm2 and a surface density of glycerol ranging from 0.1 to 10 mg/cm2.
  • 10. The method according to claim 1, further comprising providing a means for indicating the orientation of the prosthesis to the prosthesis.
  • 11. The method according to claim 10, wherein said means for indicating the orientation of the prosthesis is a zone having a different color than the rest of the prosthesis.
  • 12. The method according to claim 11, wherein providing a means for indicating the orientation of the prosthesis comprises knitting with a yarn of a different color than a yarn used for knitting said textile obtaining the zone having a different color.
  • 13. The method according to claim 11, wherein said zone having a different color of the prosthesis is situated in a medial part of the prosthesis.
  • 14. The method according to claim 1, wherein providing an openworked textile comprises knitting at least a first yarn of biocompatible polymer material to define said first and second faces, and at least a second yarn in the form of a biocompatible hot-melt monofilament to form said fastening means by melting of loops generated by said knitting said second yarn, wherein said first and second yarns are knit on a warp knitting machine with three guide bars B1, B2, B3, according to standard ISO 11676 and the following pattern chart: Bar B1: 1.0/0.1//Bar B2: 1.0/7.7/6.6/7.7//Bar B3: 2.1/5.5/3.4/0.0//said second yarn following the pattern chart of bar B3.
  • 15. The method according to claim 14, wherein said first yarn is a monofilament yarn of polyethylene terephthalate (PET) and said second yarn is a monofilament yarn of polylactic acid (PLA).
  • 16. A method for producing a prosthesis, comprising: providing an openworked textile of biocompatible material comprising a first face and a second face opposite said first face, said first face provided with fastening means that are able to fix said textile in biological tissues of an inguinal region, said textile determining in a width direction a first upper part and second lower part, and said textile in a length direction determining a zone of different color situated only in a medial part of said textile, said zone of different color including a yarn of a different color than a yarn used for forming said textile,covering only said first upper part of said second face of said textile with a non-porous coating comprising a material that is hydrosoluble at 37° C. and non-hydrosoluble at 25° C., wherein said non-porous coating comprises a mixture of non-oxidized collagen and glycerol and said non-porous coating and said zone of different color overlap on an upper medial part of said textile.
  • 17. The method of claim 16, wherein the non-oxidized collagen includes particles of pepsin-treated non-oxidized collagen.
Priority Claims (1)
Number Date Country Kind
11/62531 Dec 2011 FR national
Parent Case Info

This application is a divisional of U.S. Patent Application Ser. No. 14/366,332 filed Jun. 18, 2014, now U.S. Pat. No. 10,080,639, which is a National Stage Application of PCT/EP2012/076983 under 35USC § 371 (a), which claims priority of French Patent Application Serial No. 11/62531 filed Dec. 29, 2011, the disclosures of each of the above-identified applications are hereby incorporated by reference in their entirety.

US Referenced Citations (477)
Number Name Date Kind
1187158 Mcginley Jun 1916 A
3054406 Usher Sep 1962 A
3118294 Van Laethem Jan 1964 A
3122479 Smith Feb 1964 A
3124136 Usher Mar 1964 A
3272204 Artandi et al. Sep 1966 A
3276448 Kronenthal Oct 1966 A
3320649 Naimer May 1967 A
3364200 Ashton et al. Jan 1968 A
3570482 Shigeru et al. Mar 1971 A
3718725 Hamano Feb 1973 A
4006747 Kronenthal et al. Feb 1977 A
4060081 Yannas et al. Nov 1977 A
4173131 Melton et al. Nov 1979 A
4193137 Heck Mar 1980 A
4248064 Odham Feb 1981 A
4294241 Miyata Oct 1981 A
4307717 Hymes et al. Dec 1981 A
4338800 Matsuda Jul 1982 A
4476697 Schafer et al. Oct 1984 A
4487865 Balazs et al. Dec 1984 A
4500676 Balazs et al. Feb 1985 A
4511653 Play et al. Apr 1985 A
4527404 Nakagaki et al. Jul 1985 A
4563184 Korol Jan 1986 A
4591501 Cioca May 1986 A
4597762 Walter et al. Jul 1986 A
4603695 Ikada et al. Aug 1986 A
4631932 Sommers Dec 1986 A
4670014 Huc et al. Jun 1987 A
4709562 Matsuda Dec 1987 A
4728642 Pawelchak et al. Mar 1988 A
4748078 Doi et al. May 1988 A
4759354 Quarfoot Jul 1988 A
4769038 Bendavid et al. Sep 1988 A
4796603 Dahlke et al. Jan 1989 A
4813942 Alvarez Mar 1989 A
4841962 Berg et al. Jun 1989 A
4854316 Davis Aug 1989 A
4925294 Geshwind et al. May 1990 A
4931546 Tardy et al. Jun 1990 A
4942875 Hlavacek et al. Jul 1990 A
4948540 Nigam Aug 1990 A
4950483 Ksander et al. Aug 1990 A
4970298 Silver et al. Nov 1990 A
4976737 Leake Dec 1990 A
5002551 Linsky et al. Mar 1991 A
5015584 Brysk May 1991 A
5116357 Eberbach May 1992 A
5147374 Fernandez Sep 1992 A
5162430 Rhee et al. Nov 1992 A
5171273 Silver et al. Dec 1992 A
5176692 Wilk et al. Jan 1993 A
5192301 Kamiya et al. Mar 1993 A
5195542 Gazielly et al. Mar 1993 A
5196185 Silver et al. Mar 1993 A
5201745 Tayot et al. Apr 1993 A
5201764 Kelman et al. Apr 1993 A
5206028 Li Apr 1993 A
5217493 Raad et al. Jun 1993 A
5254133 Seid Oct 1993 A
5256418 Kemp et al. Oct 1993 A
5258000 Gianturco Nov 1993 A
5263983 Yoshizato et al. Nov 1993 A
5304595 Rhee et al. Apr 1994 A
5306500 Rhee et al. Apr 1994 A
5324775 Rhee et al. Jun 1994 A
5328955 Rhee et al. Jul 1994 A
5334527 Brysk Aug 1994 A
5339657 Mcmurray Aug 1994 A
5350583 Yoshizato et al. Sep 1994 A
5356432 Rutkow et al. Oct 1994 A
5368549 Mcvicker Nov 1994 A
5368602 Torre Nov 1994 A
5370650 Jonathan et al. Dec 1994 A
5376375 Rhee et al. Dec 1994 A
5376376 Li Dec 1994 A
5397331 Himpens et al. Mar 1995 A
5399361 Song et al. Mar 1995 A
5413791 Rhee et al. May 1995 A
5425740 Hutchinson, Jr. Jun 1995 A
5428022 Palefsky et al. Jun 1995 A
5433996 Kranzler et al. Jul 1995 A
5441491 Verschoor et al. Aug 1995 A
5441508 Gazielly et al. Aug 1995 A
5456693 Conston et al. Oct 1995 A
5456711 Hudson Oct 1995 A
5466462 Rosenthal et al. Nov 1995 A
5480644 Freed Jan 1996 A
5487895 Dapper et al. Jan 1996 A
5490984 Freed Feb 1996 A
5512291 Li Apr 1996 A
5512301 Song et al. Apr 1996 A
5514181 Light et al. May 1996 A
5522840 Krajicek Jun 1996 A
5523348 Rhee et al. Jun 1996 A
5536656 Kemp et al. Jul 1996 A
5543441 Rhee et al. Aug 1996 A
5565210 Rosenthal et al. Oct 1996 A
5567806 Abdul-Malak et al. Oct 1996 A
5569273 Titone et al. Oct 1996 A
RE35399 Eisenberg Dec 1996 E
5593441 Lichtenstein et al. Jan 1997 A
5595621 Light et al. Jan 1997 A
5601571 Moss Feb 1997 A
5607474 Athanasiou et al. Mar 1997 A
5607590 Shimizu Mar 1997 A
5614587 Rhee et al. Mar 1997 A
5618551 Tardy et al. Apr 1997 A
5634931 Kugel Jun 1997 A
5639796 Lee Jun 1997 A
5665391 Lea Sep 1997 A
5667839 Berg Sep 1997 A
5676967 Williams et al. Oct 1997 A
5681568 Goldin et al. Oct 1997 A
5686090 Schilder et al. Nov 1997 A
5686115 Vournakis et al. Nov 1997 A
5690675 Sawyer et al. Nov 1997 A
5695525 Mulhauser et al. Dec 1997 A
5697978 Sgro Dec 1997 A
5700476 Rosenthal et al. Dec 1997 A
5700477 Rosenthal et al. Dec 1997 A
5702416 Kieturakis et al. Dec 1997 A
5709934 Bell et al. Jan 1998 A
5711960 Shikinami Jan 1998 A
5716409 Debbas Feb 1998 A
5720981 Eisinger Feb 1998 A
5732572 Litton Mar 1998 A
5743917 Saxon Apr 1998 A
5749895 Sawyer et al. May 1998 A
5752974 Rhee et al. May 1998 A
5766246 Mulhauser et al. Jun 1998 A
5766631 Arnold Jun 1998 A
5769864 Kugel Jun 1998 A
5771716 Schlussel Jun 1998 A
5785983 Furlan et al. Jul 1998 A
5800541 Rhee et al. Sep 1998 A
5814328 Gunasekaran Sep 1998 A
5833705 Ken et al. Nov 1998 A
5840011 Landgrebe et al. Nov 1998 A
5861034 Taira et al. Jan 1999 A
5863984 Doillon et al. Jan 1999 A
5869080 Mcgregor et al. Feb 1999 A
5871767 Dionne et al. Feb 1999 A
5876444 Lai Mar 1999 A
5891558 Bell et al. Apr 1999 A
5899909 Claren et al. May 1999 A
5906937 Sugiyama et al. May 1999 A
5910149 Kuzmak Jun 1999 A
5911731 Pham et al. Jun 1999 A
5916225 Kugel Jun 1999 A
5919232 Chaffringeon et al. Jul 1999 A
5919233 Knopf et al. Jul 1999 A
5922026 Chin Jul 1999 A
5931165 Reich et al. Aug 1999 A
5942278 Hagedorn et al. Aug 1999 A
5962136 Dewez et al. Oct 1999 A
5972022 Huxel Oct 1999 A
RE36370 Li Nov 1999 E
5993844 Abraham et al. Nov 1999 A
5994325 Roufa et al. Nov 1999 A
5997895 Narotam et al. Dec 1999 A
6001895 Harvey et al. Dec 1999 A
6008292 Lee et al. Dec 1999 A
6015844 Harvey et al. Jan 2000 A
6039686 Robert Mar 2000 A
6042534 Gellman et al. Mar 2000 A
6042592 Schmitt Mar 2000 A
6043089 Sugiyama et al. Mar 2000 A
6051425 Morota et al. Apr 2000 A
6056688 Benderev et al. May 2000 A
6056970 Greenawalt et al. May 2000 A
6057148 Sugiyama et al. May 2000 A
6063396 Kelleher May 2000 A
6066776 Goodwin et al. May 2000 A
6066777 Benchetrit May 2000 A
6071292 Makower et al. Jun 2000 A
6077281 Das Jun 2000 A
6080194 Pachence et al. Jun 2000 A
6083522 Chu et al. Jul 2000 A
6090116 D Aversa et al. Jul 2000 A
6113623 Sgro Sep 2000 A
6120539 Eldridge et al. Sep 2000 A
6132765 Dicosmo et al. Oct 2000 A
6143037 Goldstein et al. Nov 2000 A
6153292 Bell et al. Nov 2000 A
6162962 Hinsch et al. Dec 2000 A
6165488 Tardy et al. Dec 2000 A
6171318 Kugel et al. Jan 2001 B1
6174320 Kugel et al. Jan 2001 B1
6176863 Kugel et al. Jan 2001 B1
6179872 Bell et al. Jan 2001 B1
6180848 Flament et al. Jan 2001 B1
6191334 Patterson Feb 2001 B1
6197325 Macphee et al. Mar 2001 B1
6197934 Devore et al. Mar 2001 B1
6197935 Doillon et al. Mar 2001 B1
6210439 Firmin et al. Apr 2001 B1
6214020 Mulhauser et al. Apr 2001 B1
6221109 Geistlich et al. Apr 2001 B1
6224616 Kugel May 2001 B1
6241768 Agarwal et al. Jun 2001 B1
6258124 Darois et al. Jul 2001 B1
6262332 Ketharanathan Jul 2001 B1
6264702 Ory et al. Jul 2001 B1
6267772 Mulhauser et al. Jul 2001 B1
6270530 Eldridge et al. Aug 2001 B1
6277397 Shimizu Aug 2001 B1
6280453 Kugel et al. Aug 2001 B1
6287316 Agarwal et al. Sep 2001 B1
6290708 Kugel et al. Sep 2001 B1
6306079 Trabucco Oct 2001 B1
6306424 Vyakarnam et al. Oct 2001 B1
6312474 Francis et al. Nov 2001 B1
6319264 Tormala et al. Nov 2001 B1
6328686 Robert Dec 2001 B1
6334872 Termin et al. Jan 2002 B1
6337389 Wolfinbarger, Jr. Jan 2002 B1
6383201 Dong May 2002 B1
6391060 Ory et al. May 2002 B1
6391333 Li et al. May 2002 B1
6391939 Tayot et al. May 2002 B2
6408656 Ory et al. Jun 2002 B1
6410044 Chudzik et al. Jun 2002 B1
6413742 Olsen et al. Jul 2002 B1
6425924 Rousseau Jul 2002 B1
6428978 Olsen et al. Aug 2002 B1
6436030 Rehil Aug 2002 B2
6440167 Shimizu Aug 2002 B2
6443964 Ory et al. Sep 2002 B1
6447551 Goldmann Sep 2002 B1
6447802 Sessions et al. Sep 2002 B2
6448378 Devore et al. Sep 2002 B2
6451032 Ory et al. Sep 2002 B1
6451301 Sessions et al. Sep 2002 B1
6454787 Maddalo et al. Sep 2002 B1
6477865 Matsumoto Nov 2002 B1
6479072 Morgan et al. Nov 2002 B1
6485503 Jacobs et al. Nov 2002 B2
6500464 Ceres et al. Dec 2002 B2
6500777 Wiseman et al. Dec 2002 B1
6509031 Miller et al. Jan 2003 B1
6511958 Atkinson et al. Jan 2003 B1
6514286 Leatherbury et al. Feb 2003 B1
6514514 Atkinson et al. Feb 2003 B1
6540773 Dong Apr 2003 B2
6541023 Andre et al. Apr 2003 B1
6548077 Gunasekaran Apr 2003 B1
6554855 Dong Apr 2003 B1
6559119 Burgess et al. May 2003 B1
6566345 Miller et al. May 2003 B2
6575988 Rousseau Jun 2003 B2
6576019 Atala Jun 2003 B1
6596002 Therin et al. Jul 2003 B2
6596304 Bayon Jul 2003 B1
6599323 Melican et al. Jul 2003 B2
6599524 Li et al. Jul 2003 B2
6599690 Abraham et al. Jul 2003 B1
6610006 Amid et al. Aug 2003 B1
6613348 Jain Sep 2003 B1
6616685 Rousseau Sep 2003 B2
6623963 Mueller et al. Sep 2003 B1
6627215 Dale et al. Sep 2003 B1
6630414 Matsumoto Oct 2003 B1
6637437 Hungerford et al. Oct 2003 B1
6638284 Rousseau et al. Oct 2003 B1
6645226 Jacobs et al. Nov 2003 B1
6652594 Francis et al. Nov 2003 B2
6652595 Nicolo Nov 2003 B1
6653450 Berg et al. Nov 2003 B1
6656206 Corcoran et al. Dec 2003 B2
6660280 Allard et al. Dec 2003 B1
6669735 Pelissier Dec 2003 B1
6670018 Fujita et al. Dec 2003 B2
6682760 Noff et al. Jan 2004 B2
6685714 Rousseau Feb 2004 B2
6706684 Bayon et al. Mar 2004 B1
6706690 Reich et al. Mar 2004 B2
6712859 Rousseau et al. Mar 2004 B2
6719795 Bryan et al. Apr 2004 B1
6723335 Moehlenbruck et al. Apr 2004 B1
6726660 Hessel et al. Apr 2004 B2
6730299 Tayot et al. May 2004 B1
6736823 Darois et al. May 2004 B2
6736854 Vadurro et al. May 2004 B2
6737371 Planck et al. May 2004 B1
6743435 Devore et al. Jun 2004 B2
6746458 Cloud Jun 2004 B1
6752834 Geistlich et al. Jun 2004 B2
6755868 Rousseau Jun 2004 B2
6773723 Spiro et al. Aug 2004 B1
6783554 Amara et al. Aug 2004 B2
6790213 Cherok et al. Sep 2004 B2
6790454 Abdul et al. Sep 2004 B1
6800082 Rousseau Oct 2004 B2
6833408 Sehl et al. Dec 2004 B2
6835336 Watt Dec 2004 B2
6852330 Bowman et al. Feb 2005 B2
6869938 Schwartz et al. Mar 2005 B1
6872227 Sump et al. Mar 2005 B2
6893653 Abraham et al. May 2005 B2
6896904 Spiro et al. May 2005 B2
6926723 Mulhauser et al. Aug 2005 B1
6936276 Spiro et al. Aug 2005 B2
6939562 Spiro et al. Sep 2005 B2
6949625 Tayot Sep 2005 B2
6966918 Schuldt-Hempe et al. Nov 2005 B1
6971252 Therin et al. Dec 2005 B2
6974679 Andre et al. Dec 2005 B2
6974862 Ringeisen et al. Dec 2005 B2
6977231 Matsuda Dec 2005 B1
6984392 Bechert et al. Jan 2006 B2
6988386 Okawa et al. Jan 2006 B1
7011688 Gryska et al. Mar 2006 B2
7021086 Ory et al. Apr 2006 B2
7022358 Eckmayer et al. Apr 2006 B2
7025063 Snitkin et al. Apr 2006 B2
7041868 Greene et al. May 2006 B2
7060103 Carr et al. Jun 2006 B2
RE39172 Bayon et al. Jul 2006 E
7070558 Gellman et al. Jul 2006 B2
7087065 Ulmsten et al. Aug 2006 B2
7094261 Zotti et al. Aug 2006 B2
7098315 Schaufler Aug 2006 B2
7101381 Ford et al. Sep 2006 B2
7115220 Dubson et al. Oct 2006 B2
7156804 Nicolo Jan 2007 B2
7156858 Schuldt-Hempe et al. Jan 2007 B2
7175852 Simmoteit et al. Feb 2007 B2
7192604 Brown et al. Mar 2007 B2
7207962 Anand et al. Apr 2007 B2
7214765 Ringeisen et al. May 2007 B2
7226611 Yura et al. Jun 2007 B2
7229453 Anderson et al. Jun 2007 B2
7252837 Guo et al. Aug 2007 B2
7279177 Looney et al. Oct 2007 B2
7331199 Ory et al. Feb 2008 B2
7393319 Merade et al. Jul 2008 B2
7556598 Rao Jul 2009 B2
7594921 Browning Sep 2009 B2
7614258 Cherok et al. Nov 2009 B2
7615065 Priewe et al. Nov 2009 B2
7662169 Wittmann Feb 2010 B2
7670380 Cauthen, III et al. Mar 2010 B2
7682381 Rakos et al. Mar 2010 B2
7709017 Tayot et al. May 2010 B2
7718556 Matsuda et al. May 2010 B2
7732354 Fricke et al. Jun 2010 B2
7785334 Ford et al. Aug 2010 B2
7789888 Bartee et al. Sep 2010 B2
7799767 Lamberti et al. Sep 2010 B2
7806905 Ford et al. Oct 2010 B2
7824420 Eldridge et al. Nov 2010 B2
7828854 Rousseau et al. Nov 2010 B2
7900484 Cherok et al. Mar 2011 B2
7931695 Ringeisen Apr 2011 B2
8052759 Dupic et al. Nov 2011 B2
8079023 Chen Dec 2011 B2
8100924 Browning Jan 2012 B2
8123817 Intoccia et al. Feb 2012 B2
8142515 Therin et al. Mar 2012 B2
8157821 Browning Apr 2012 B2
8157822 Browning Apr 2012 B2
8182545 Cherok et al. May 2012 B2
8197837 Jamiolkowski et al. Jun 2012 B2
8206632 Rousseau et al. Jun 2012 B2
8215310 Browning Jul 2012 B2
8317872 Adams Nov 2012 B2
8323675 Greenawalt Dec 2012 B2
8343232 Adzich et al. Jan 2013 B2
8366787 Brown et al. Feb 2013 B2
8435307 Paul May 2013 B2
8470355 Skalla et al. Jun 2013 B2
8562633 Cully et al. Oct 2013 B2
8574627 Martakos et al. Nov 2013 B2
8709094 Stad et al. Apr 2014 B2
8734471 Deitch May 2014 B2
8753360 Gleiman et al. Jun 2014 B2
8758800 Stopek et al. Jun 2014 B2
8784294 Goddard Jul 2014 B2
8814887 Walther et al. Aug 2014 B2
8828092 Toso et al. Sep 2014 B2
8834864 Odar et al. Sep 2014 B2
8846060 Archibald et al. Sep 2014 B2
8865215 Ladet et al. Oct 2014 B2
8877233 Obermiller et al. Nov 2014 B2
8911504 Mathisen et al. Dec 2014 B2
8920370 Sholev et al. Dec 2014 B2
8956373 Ford et al. Feb 2015 B2
8962006 Bayon et al. Feb 2015 B2
8968762 Ladet et al. Mar 2015 B2
8979935 Lozier et al. Mar 2015 B2
9034357 Stopek May 2015 B2
9113993 Lee Aug 2015 B2
9211175 Stopek et al. Dec 2015 B2
9216075 Bailly et al. Dec 2015 B2
20010008930 Tayot Jul 2001 A1
20020087174 Capello Jul 2002 A1
20020095218 Carr et al. Jul 2002 A1
20020132240 Ashkenazi Sep 2002 A1
20030086975 Ringeisen May 2003 A1
20030114937 Leatherbury et al. Jun 2003 A1
20030133967 Ruszczak et al. Jul 2003 A1
20030225355 Butler Dec 2003 A1
20040034373 Schuldt-Hempe et al. Feb 2004 A1
20040054376 Ory et al. Mar 2004 A1
20040059356 Gingras Mar 2004 A1
20040062910 Morrison Apr 2004 A1
20040101546 Gorman et al. May 2004 A1
20050002893 Goldmann Jan 2005 A1
20050021058 Negro Jan 2005 A1
20050085924 Darois et al. Apr 2005 A1
20050113849 Popadiuk et al. May 2005 A1
20050137512 Campbell et al. Jun 2005 A1
20050142161 Freeman et al. Jun 2005 A1
20050148963 Brennan Jul 2005 A1
20050175659 Macomber et al. Aug 2005 A1
20050232979 Shoshan Oct 2005 A1
20050267521 Forsberg Dec 2005 A1
20050288691 Leiboff Dec 2005 A1
20060116696 Odermatt et al. Jun 2006 A1
20060135921 Wiercinski et al. Jun 2006 A1
20060147501 Hillas et al. Jul 2006 A1
20060216320 Kitazono et al. Sep 2006 A1
20060252981 Matsuda et al. Nov 2006 A1
20060253203 Alvarado Nov 2006 A1
20060282103 Fricke et al. Dec 2006 A1
20070088391 Mcalexander et al. Apr 2007 A1
20070129736 Solecki Jun 2007 A1
20070198040 Buevich et al. Aug 2007 A1
20070299538 Roeber Dec 2007 A1
20080091276 Deusch et al. Apr 2008 A1
20080109017 Herweck et al. May 2008 A1
20080113001 Herweck et al. May 2008 A1
20080172071 Barker Jul 2008 A1
20080243149 Kockerling Oct 2008 A1
20080255593 St-Germain Oct 2008 A1
20090005867 Lefranc et al. Jan 2009 A1
20090035341 Wagener et al. Feb 2009 A1
20090036996 Roeber Feb 2009 A1
20090036997 Bayon Feb 2009 A1
20090068250 Gravagna et al. Mar 2009 A1
20090105526 Piroli et al. Apr 2009 A1
20090163936 Yang et al. Jun 2009 A1
20090187197 Roeber et al. Jul 2009 A1
20090192530 Adzich et al. Jul 2009 A1
20090192532 Spinnler Jul 2009 A1
20090204129 Fronio Aug 2009 A1
20090216338 Gingras et al. Aug 2009 A1
20090240288 Guetty Sep 2009 A1
20090270999 Brown Oct 2009 A1
20090281558 Li et al. Nov 2009 A1
20090318752 Evans Dec 2009 A1
20100104608 Abuzaina et al. Apr 2010 A1
20100318108 Datta et al. Dec 2010 A1
20110015760 Kullas Jan 2011 A1
20110144667 Horton et al. Jun 2011 A1
20110190795 Hotter et al. Aug 2011 A1
20110238094 Thomas et al. Sep 2011 A1
20110251699 Ladet et al. Oct 2011 A1
20110257666 Ladet Oct 2011 A1
20110320009 Ladet Dec 2011 A1
20120010636 Boey Jan 2012 A1
20120010637 Stopek Jan 2012 A1
20120016388 Houard et al. Jan 2012 A1
20120029537 Mortarino Feb 2012 A1
20120065727 Reneker et al. Mar 2012 A1
20120082712 Stopek et al. Apr 2012 A1
20120116425 Intoccia et al. May 2012 A1
20120150204 Mortarino et al. Jun 2012 A1
20120165937 Montanari et al. Jun 2012 A1
20120179175 Hammell et al. Jul 2012 A1
20120179176 Wilson et al. Jul 2012 A1
20120197415 Montanari et al. Aug 2012 A1
20130078285 Ladet Mar 2013 A1
20140044861 Boey et al. Feb 2014 A1
20140364684 Lecuivre et al. Dec 2014 A1
Foreign Referenced Citations (136)
Number Date Country
1317836 May 1993 CA
201879864 Jun 2011 CN
19544162 Apr 1997 DE
19718903 Dec 1997 DE
19751733 Dec 1998 DE
19832634 Jan 2000 DE
10019604 Oct 2001 DE
10120942 Oct 2001 DE
10043396 Jun 2002 DE
0194192 Sep 1986 EP
0248544 Dec 1987 EP
0263360 Apr 1988 EP
0276890 Aug 1988 EP
0372969 Jun 1990 EP
0531742 Mar 1993 EP
0544485 Jun 1993 EP
0552576 Jul 1993 EP
0611561 Aug 1994 EP
0614650 Sep 1994 EP
0621014 Oct 1994 EP
0625891 Nov 1994 EP
0637452 Feb 1995 EP
0664132 Jul 1995 EP
0705878 Apr 1996 EP
0719527 Jul 1996 EP
0774240 May 1997 EP
0797962 Oct 1997 EP
0800791 Oct 1997 EP
0827724 Mar 1998 EP
0836838 Apr 1998 EP
0847727 Jun 1998 EP
0876808 Nov 1998 EP
0895762 Feb 1999 EP
0898944 Mar 1999 EP
1017415 Jul 2000 EP
1036545 Sep 2000 EP
1052319 Nov 2000 EP
1055757 Nov 2000 EP
1090590 Apr 2001 EP
1216717 Jun 2002 EP
1216718 Jun 2002 EP
0693523 Nov 2002 EP
1273312 Jan 2003 EP
1315468 Jun 2003 EP
1382728 Jan 2004 EP
1484070 Dec 2004 EP
1561480 Aug 2005 EP
1645232 Apr 2006 EP
1674048 Jun 2006 EP
1691606 Aug 2006 EP
1782848 May 2007 EP
2229918 Sep 2010 EP
2244853 Apr 1975 FR
2257262 Aug 1975 FR
2308349 Nov 1976 FR
2453231 Oct 1980 FR
2612392 Sep 1988 FR
2715309 Jul 1995 FR
2715405 Jul 1995 FR
2724563 Mar 1996 FR
2730406 Aug 1996 FR
2744906 Aug 1997 FR
2766698 Feb 1999 FR
2771622 Jun 1999 FR
2773057 Jul 1999 FR
2774277 Aug 1999 FR
2779937 Dec 1999 FR
2846548 May 2004 FR
2859624 Mar 2005 FR
2863277 Jun 2005 FR
2876020 Apr 2006 FR
2884706 Oct 2006 FR
2929834 Oct 2009 FR
2953709 Jun 2011 FR
1174814 Dec 1969 GB
2051153 Jan 1981 GB
2306110 Apr 1997 GB
H0332677 Feb 1991 JP
H05237128 Sep 1993 JP
H09137380 May 1997 JP
H11146888 Jun 1999 JP
2008538300 Oct 2008 JP
2011078767 Apr 2011 JP
8902445 Mar 1989 WO
8908467 Sep 1989 WO
9012551 Nov 1990 WO
9206639 Apr 1992 WO
9220349 Nov 1992 WO
9310731 Jun 1993 WO
9311805 Jun 1993 WO
9318174 Sep 1993 WO
9417747 Aug 1994 WO
9507666 Mar 1995 WO
9518638 Jul 1995 WO
9532687 Dec 1995 WO
9603091 Feb 1996 WO
9608277 Mar 1996 WO
9609795 Apr 1996 WO
9614805 May 1996 WO
9641588 Dec 1996 WO
9735533 Oct 1997 WO
9835632 Aug 1998 WO
9849967 Nov 1998 WO
9905990 Feb 1999 WO
9906079 Feb 1999 WO
9906080 Feb 1999 WO
9951163 Oct 1999 WO
0016821 Mar 2000 WO
0067663 Nov 2000 WO
0115625 Mar 2001 WO
0180773 Nov 2001 WO
0181667 Nov 2001 WO
0207648 Jan 2002 WO
0217853 Mar 2002 WO
02078568 Oct 2002 WO
03002168 Jan 2003 WO
2004004600 Jan 2004 WO
2004071349 Aug 2004 WO
2004078120 Sep 2004 WO
2004103212 Dec 2004 WO
2005011280 Feb 2005 WO
2005013863 Feb 2005 WO
2005018698 Mar 2005 WO
2005048708 Jun 2005 WO
2005105172 Nov 2005 WO
2006018552 Feb 2006 WO
2006023444 Mar 2006 WO
2007048099 Apr 2007 WO
2009031035 Mar 2009 WO
2009071998 Jun 2009 WO
2010043978 Apr 2010 WO
2011007062 Jan 2011 WO
2011026987 Mar 2011 WO
WO-2011026987 Mar 2011 WO
2011038740 Apr 2011 WO
2011042811 Apr 2011 WO
Non-Patent Literature Citations (43)
Entry
Canadian Office Action issued in corresponding Canadian application No. 2,858,003 dated May 3, 2019, 3 pages.
Amid, R., “Lichtenstein tension-free hernioplasty: Its inception, evolution, and principles,” Hernia, 2004; pp. 1-7, 8, published online Sep. 2003.
Australian Examination Report dated Dec. 16, 2016 in corresponding Australian Patent Application No. 2012360857, 3 pages.
Blondin, C. et al., “Inhibition of Complement Activation by Natural Sulfated Polysaccharides (Fucans) from Brown Seaweed,” Molecular Immuol., Mar. 1994, pp. 247-253, 31(4).
Blondin, C. et al., “Relationships between chemical characteristics and anticomplementary activity of fucans,” Biomaterials, Mar. 1996, pp. 597-603, 17(6).
Boisson-Vidal, C. et al., “Neoangiogenesis Induced by Progenitor Endothelial Cells: Effect of Fucoidan From Marine Algae,” Cardiovascular & Hematological Agents in Medicinal Chem., Jan. 2007, pp. 67-77, 5(1).
Bracco, P. et al., “Comparison of polypropylene and polyethylene terephthalate (Dacron) meshes for abdominal wall hernia repair: A chemical and morphological study,” Hernia, 2005, pp. 51-55, 9 (1), published online Sep. 2004.
Canadian Office Action issued in corresponding Canadian application No. 2,858,003 dated Oct. 12, 2018, 3 pages.
Dhastan, “Tension Free Open Inguinal Hernia Repair Using an Innovative Self Gripping Semi-Resorbable Mesh,” J. Min. Access. Surg., Sep. 2006, pp. 139-143, vol. 2.
Chen, G. et al., “A Hybrid Network of Synthetic Polymer Mesh and Collagen Sponge,” The Royal Society of Chemistry 2000, Chem. Commun., Jul. 2000, pp. 1505-1506.
Chinese Office Action dated Apr. 5, 2016 in corresponding Chinese Patent Application No. 201280065573.1, together with English language translation, 23 pages.
Chinese Office Action dated Oct. 21, 2016 in corresponding Chinese Patent Application No. 201280065573.1 together with English translation, 22 pages.
Chinese Office Action, Application No. 2012800655731 dated Jul. 28, 2015 and English translation.
Collins, R. et al., “Use of collagen film as a dural substitute: Preliminary animal studies,” Journal of Biomedical aterials Research, Feb. 1991, pp. 267-276, vol. 25.
Covidien, “Parietex ProGrip Self-Fixating Mesh,” Hernia Repair Products, retrieved Dec. 7, 2012, http://www.covidien.com/campaigns/pagebuilder.aspx?topiciD=172431 &page=Hernia:Parietex>, pp. 1-2.
Covidien, “Procedures Parietex ProGrip Self-Fixating Mesh,” Hernia Solutions, retrieved Dec. 7, 2012, (select United States), pp. 1-2.
Dixit et al., “Oral Strip Technology: Overview and Future Potential,” Journal of Controlled Release, Jun. 2009, pp. 34-107, vol. 139.
Dr. S. Raz, “The Karl Mayer Guide to Tehnical Textiles,” Jan. 2000, pp. 1-36, Obertshausen, Germany.
Ellouali, M. et al., “Antitumor Activity of Low Molecular Weight Fucans Extracted from Brown Seaweed Ascophyllum nodosum,” Anticancer Res , Nov.-Dec. 1993, pp. 2011-2020, 12 (6A).
European Office Action dated Dec. 19, 2017 in corresponding European Patent Application No. 12812670.3, 3 pages.
Haneji, K. et al., “Fucoidan extracted from Cladosiphon Okamuranus Tokida Induces Apoptosis of Human T-cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells,” Nutrition and Cancer, 2005, pp. 189-201, 52(2), published online Nov. 2009.
Haroun-Bouhedja, F. et al., “In Vitro Effects of Fucans on MDA-MB231 Tumor Cell Adhesion and Invasion,” Anticancer Res., Jul.-Aug. 2002, pp. 2285-2292, 22(4).
Haroun-Bouhedja, F. et al., “Relationship between sulfate groups and biological activities of fucans,” Thrombosis Res., Dec. 2000, pp. 453-459, 100(5).
Hirano, S. et al., “The blood biocompatibility of chitosan and N-acylchitosans,” J. Biomed. Mater. Res., Apr. 1985, 413-417, 19.
International Search Report for PCT/EP12/076983 date of completion is Mar. 11, 2013 (3 pages).
Junge, K. et al., “Functional and Morphologic Properties of a Modified Mesh for Inguinal Hernia Repair,” World J. Surg., Sep. 2002, pp. 1472-1480, 26.
Kanabar, V. et al., “Some structural determinants of the antiproliferative effect of heparin-like molecules on human airway smooth muscle,” Br. J. Pharmacol., Oct. 2005, pp. 370-777, 146(3).
Klinge, U. et al., “Foreign Body Reaction to Meshes Used for the Repair of Abdominal Wall Hernias,” Eur J. Surg, Sep. 1999, pp. 665-673, 165.
Klinge, U. et al., “Functional and Morphological Evaluation of a Low-Weight, Monofilament Polypropylene Mesh for Hernia Repair,” J Biomed. Mater. Res., Jan. 2002, pp. 129-136, 63.
Langenbech, M. R. et al., “Comparison of biomaterials in the early postoperative period,” Surg Endosc., May 2003, pp. 1105-1109, 17 (7).
Logeart, D. et al., “Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. II. Degradation and molecular weight effect,” Eur. J. Cell. Biol., Dec. 1997, pp. 385-390, 74(4).
Malette, W. G. et al., “Chitosan, A New Hemostatic,” Ann Th. Surg., Jul. 1983, pp. 55-58, 36.
Muzzarelli, R. et al., “Reconstruction of parodontal tissue with chitosan,” Biomaterials, Nov. 1989, pp. 598-604, 10.
O'Dwyer, P. et al., “Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair,” Br. J. Surg., Feb. 2005, pp. 166-170, 92(2).
Prokop, A. et al., “Water Soluble Polymers for Immunoisolation I: Complex Coacevation and Cytotoxicity,” Advances in Polymer Science, Jul. 1998, pp. 1-51, 136.
Rao, B. et al., “Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential,” J. Biomed. Mater. Res., Jan. 1997, pp. 21-28, 34.
Rosen, M. et al., “Laparoscopic component separation in the single-stage treatment of infected abdominal wall prosthetic removal,” Hernia, 2007, pp. 435-440, 11, published online Jul. 2007.
Scheidbach, H. et al., “In vivo studies comparing the biocompatibility of various polypropylene meshes and their handling properties during endoscopic total extraperitoneal (TEP) patchplasty: An experimental study in pigs,” Surg. Endosc., Feb. 2004, pp. 211-220, 18(2).
Strand, S. et al., “Screening of Chitosans and Conditions for Bacterial Flocculation,” Biomacromolecules, Mar. 2001, 126-133, 2.
Varum, K. et al., “In vitro degradation rates of partially N-acetylated chitosans in human serum,” Carbohydrate Research, Mar. 1997, pp. 99-101, 299.
Welty, G. et al., “Functional impairment and complaints following incisional hernia repair with different polypropylene meshes,” Hernia, Aug. 2001; pp. 142-147, 5.
Zyagintseva, T. et al., “Inhibition of complement activation by water-soluble polysaccharides of some far-eastern brown seaweeds,” Comparative Biochem and Physiol, Jul. 2000, pp. 209-215, 126(3).
Communication pursuant to Article 94(3) EPC issued in European Application No. 12812670.3 dated Jul. 28, 2020, 5 pages.
Related Publications (1)
Number Date Country
20190008625 A1 Jan 2019 US
Divisions (1)
Number Date Country
Parent 14366332 US
Child 16128549 US